Revealing alcohol abuse: To ask or to test?

被引：13

作者：

Alling, C

Chick, JD

Anton, R

Mayfield, RD

Salaspuro, M

Helander, A

Harris, RA

机构：

[1] Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA

[2] Univ Lund Hosp, Dept Lab Med, S-22185 Lund, Sweden

[3] Univ Edinburgh, Dept Psychiat, Edinburgh EH8 9YL, Midlothian, Scotland

[4] Med Univ S Carolina, Ctr Drug & Alcohol Programs, Charleston, SC 29425 USA

[5] Univ Helsinki, Res Unit Subst Aduse Med, FIN-00014 Helsinki, Finland

[6] Karolinska Inst, Stockholm, Sweden

[7] Univ Hosp, Alcohol Lab, Stockholm, Sweden

来源：

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2005年 / 29卷 / 07期

关键词：

biomarker; genomic; proteomic; alcoholism; alcohol abuse;

D O I：

10.1097/01.ALC.0000171489.55856.A5

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

This article represents the proceedings of a symposium at the 2004 ISBRA Congress in Heidelberg/Mannheim, Germany. The chairs were C. Alling and R. A. Harris. The presentations were (1) Advantage and Disadvantage of Tests for Self-Reported Intake in Different Settings, by J. D. Chick; (2) Update on the Use of Biological Markers to Monitor Outcome in Alcoholism Clinical Treatment Trials, by R. Anton; (3) Identification of Alcohol Biomarkers Using Genomic and Proteomic Approaches, by R. D. Mayfield; (4) Use of Biomarkers as Secondary or Primary Outcome Measures in Alcoholism Treatment Trials, by M. Salaspuro; and (5) Use of Tests for Drink-Drive Offenders: A European Perspective, by A. Helander.

引用

页码：1257 / 1263

页数：7

共 46 条

[1] Aertgeerts B, 2001, BRIT J GEN PRACT, V51, P206
[2] Allen JP, 2001, ALCOHOL CLIN EXP RES, V25, P1119
[3] Laboratory markers carbohydrate-deficient transferrin, γ-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population:: Results from the study of health in Pomerania (SHIP)
Alte, D
Luedemann, J
Rose, HJ
John, U
[J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (06) : 931 - 940
[4] A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence
Anton, RF
Pettinati, H
Zweben, A
Kranzler, HR
Johnson, B
Bohn, MJ
McCaul, ME
Anthenelli, R
Salloum, I
Galloway, G
Garbutt, J
Swift, R
Gastfriend, D
Kallio, A
Karhuvaara, S
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (04) : 421 - 428
[5] Carbohydrate-deficient transferrin and γ-glutamyltransferase for the detection and monitoring of alcohol use:: Results from a multisite study
Anton, RF
Lieber, C
Tabakoff, B
[J]. ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2002, 26 (08): : 1215 - 1222
[6] CARBOHYDRATE-DEFICIENT TRANSFERRIN AND GAMMA-GLUTAMYL-TRANSFERASE AS MARKERS OF HEAVY ALCOHOL-CONSUMPTION - GENDER DIFFERENCES
ANTON, RF
MOAK, DH
[J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1994, 18 (03) : 747 - 754
[7] ANTON RF, 2005, IN PRESS J CLIN PSYC
[8] 5-Hydroxytryptophol as a marker for recent alcohol intake
Beck, O
Helander, A
[J]. ADDICTION, 2003, 98 : 63 - 72
[9] Possibility of improving the acceptance rate of early detection testing for prostate cancer with a one-step test for prostate-specific antigen in whole blood
Berg, W
Linder, C
Eschholz, G
Link, S
Schubert, J
[J]. UROLOGIA INTERNATIONALIS, 1999, 63 (02) : 102 - 106
[10] A diagnostic test for prostate cancer from gene expression profiling data
Bueno, R
Loughlin, KR
Powell, MH
Gordon, GJ
[J]. JOURNAL OF UROLOGY, 2004, 171 (02) : 903 - 906

← 1 2 3 4 5 →